Company intelligence / Profile preview

Shenzhou Cell Engineering Co., Ltd.

Beijing, Beijing Shi, Chinasinocelltech.com ↗

Ownership: Private
Development stage: Other

Overview

Shenzhou Cell Engineering has developed a rich product pipeline spanning oncology, autoimmune disorders, genetic diseases and preventive vaccines. It has achieved approvals for biosimilars such as adalimumab for Crohn’s disease and advanced vaccine candidates into late-stage clinical trials. Its SCTB35 bispecific antibody targeting CD20xCD3 entered Phase I trials in relapsed/refractory B-cell non-Hodgkin lymphoma in early/mid‑2024. The company leverages robust proprietary technology platforms covering both upstream cell engineering/bioprocessing and downstream product development.

Therapeutic areas: OncologyRare DiseasesImmunologyGastroenterologyInfectious Diseases
Modalities: Monoclonal antibodies (mAbs)Therapeutic vaccinesMultivalent vaccinesBiosimilarsBispecific antibodies
Industry: Biotech

Drug pipeline

3 assets

SCTB35

2 more assets in the full pipeline.

Beyond the preview

Go deeper on Shenzhou Cell Engineering Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenzhou Cell Engineering Co., Ltd..